COURT-RULING ·Filed Sep 11, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed19d 16h ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight • Neutral

This is a non-event for MRK. The underlying case remains pending with no substantive ruling. Monitor for future dispositive motions or trial dates, but this order has no trading implications.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
MRK ▲ +2.04% at T+5d
NEUTRAL call ✓ call won +2.04% · α vs SPY +2.26% · entry $143.93 → $146.87
Next anchor: T+20d in 6d
Latest observation: T+13 +2.37% FF3 residual α
Entry anchored
Sep 10, 07:28 PM ET
via 1-min bar
T+1d
+0.64%
call +0.64% · α +1.09%
$144.85
settled 21d ago
T+5d
+2.04%
call +2.04% · α +2.26%
$146.87
settled 15d ago
T+20d
—
call — · α —
—
in 6d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

This is a routine procedural order granting pro hac vice admission for an attorney in the ongoing case Kaiser Foundation Health Plan Inc v. Merck & Co., Inc. The order does not address any substantive legal issues, liability, damages, or injunctive relief. It has no material impact on Merck's business, financials, or stock price.

Court Ruling Details

Ruling Date
Sep 11, 2026
Court
United States District Court for the Northern District of California
Court Level
District
Case Type
contract
Ruling Type
procedural
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW

Key Facts

  • The court granted an application for pro hac vice admission for an attorney representing plaintiff Kaiser Foundation Health Plan, Inc.
  • The order is purely procedural and does not rule on any substantive motion or the merits of the case.
  • No damages, injunction, or financial exposure is mentioned in the document.

Financial Impact

None — no financial impact from this procedural order.

Risk Factors

  • The underlying litigation (Kaiser v. Merck) remains unresolved and could eventually result in material exposure, but this procedural order does not change that risk profile.

Market Snapshot

Price
$144.07
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
72% bullish (36 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-113db93b5e-MRK
20 reports for MRK
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +18.67%Aug 6, 2026
Filters
Rows
Reports for MRK — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Court Ruling
NEUTRAL ★ 1/10
$143.93 $146.87▲ +2.04%▲ +2.26%$143.57 (−0.25%)
Sep 9, 2026
23d ago
Court Ruling
NEUTRAL ★ 1/10
$147.53 $144.91▼ −1.78%▼ −1.12%$143.57 (−2.68%)
Aug 27, 2026
5w ago
Court Ruling
NEUTRAL ★ 1/10
$149.54 $152.34▲ +1.87%▲ +1.60%$143.57 (−3.99%)
Aug 24, 2026
5w ago
Court Ruling
BEARISH ★ 5/10
$150.66 $147.73▲ +1.95%▲ +2.42%$143.57 (+4.71%)
Aug 20, 2026
6w ago
ANALYST-UPGRADE
MIXED ★ 5/10
$148.99 $149.54▲ +0.37%▼ −0.75%$143.57 (−3.64%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.84 $152.55▲ +12.30%▲ +13.67%$143.57 (+5.69%)
Aug 13, 2026
7w ago
Court Ruling
NEUTRAL ★ 3/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.57 (+5.92%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.57 (+5.92%)
Aug 12, 2026
7w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.57 (+8.01%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.57 (+8.01%)
Showing 10 of 20

US Market Status

Market Open — Closes in 6h 26m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access